This paper describes the development of an artificial intelligence (AI) system for survival prediction from intraocular melanoma. The system used artificial neural networks (ANNs) with five input parameters: coronal and sagittal tumour location, anterior tumour margin, largest basal tumour diameter and the cell type. After excluding records with missing data, 2331 patients were included in the study. These were split randomly into training and test sets. Date censorship was applied to the records to deal with patients who were lost to follow-up and patients who died from general causes. Bayes theorem was then applied to the ANN output to construct survival probability curves. A validation set with 34 patients unseen to both training and test sets was used to compare the AI system with Cox's regression (CR) and Kaplan-Meier (KM) analyses. Results showed large differences in the mean 5 year survival probability figures when the number of records with matching characteristics was small. However, as the number of matches increased to >100 the system tended to agree with CR and KM. The validation set was also used to compare the system with a clinical expert in predicting time to metastatic death. The rms error was 3.7 years for the system and 4.3 years for the clinical expert for 15 years survival. For <10 years survival, these figures were 2.7 and 4.2, respectively. We concluded that the AI system can match if not better the clinical expert's prediction. There were significant differences with CR and KM analyses when the number of records was small, but it was not known which model is more accurate.
Introduction
Survival modelling is important in oncology, because it provides an indication of prognosis, enables special measures to be targeted at high-risk individuals and enhances the evaluation of clinical procedures. Traditionally, survival data have been analysed using statistical methods such as Cox's regression (CR) analysis to construct survival prediction functions in various types of cancer (Cintin et al 2002 , Gamel and Jones 1993 , Pollack et al 2002 , Richter et al 2002 , Seagard and Kock 1995 , Shields 2000 . These methods require previous knowledge of the correct functional relationship between predictive variables, which may not be available (Lisboa 2002) . Another problem is uncertainty caused by missing data (Frize et al 2001) .
Artificial neural networks (ANNs) have been used in conjunction with statistical methods to model survival in cancer (Ripley and Ripley 2001) . As with statistical methods, ANNs allow the mixture of categorical and continuous variables. ANNs may offer advantages over linear statistical models. They allow (1) arbitrary nonlinear relationships between independent and dependent variables and (2) all possible interactions between dependent variables. Moreover, ANNs do not require explicit distributional assumption. Their main disadvantage is their 'black box' nature making it difficult to get an insight into the problem. A study comparing ANNs with statistical regression analysis has found that for smaller sample sizes (n < 2000) the ANNs tended to outperform regression (Sargent 2001) . The study however could not rule out the possibility of publication bias.
A common problem in survival modelling is loss to follow-up of the subjects (Lisboa 2002 ) that could be due to changing address or death from an unrelated cause. These subjects can only be included during the time period they were observed and omitted (censored) afterwards (Ravdin and Clark 1992) . The application of ANNs to censored data provides potential advantages over traditional linear models based on standard assumptions, e.g. proportional hazards. ANNs deal with the censorship issue by including time as one of the covariates. By including each patient only for the time intervals where the outcome is observed and omitting them when it is unknown, the network weights are optimized to a partial loglikelihood. This is described thoroughly in the literature as a partial logistic artificial neural network (PLANN) model (Biganzoli et al 1998) . The combination of ANNs with probabilistic algorithms has been explored and proved to be a powerful technique in survival prediction studies (Le Goff et al 2000 , Lisboa et al 2003 , Sierra and Larranaga 1998 . In this paper however, we describe a new method for combining ANNs with Bayes theorem to model survival from intraocular melanoma.
Intraocular melanoma is a highly malignant tumour, which threatens the patient with irreversible visual deficit, pain, loss of the eye and metastatic death (Damato 2000) . Previously, the standard form of treatment was enucleation, whereas today the treatment is usually aimed at conserving the eye with as much vision as possible. This is achieved by a variety of treatment modalities, which include proton beam radiotherapy, plaque radiotherapy, transscleral local resection, trans-retinal local resection (i.e. endoresection) and transpupillary thermotherapy. Approximately 50% of all patients ultimately develop metastatic disease, which is invariably fatal. Features predictive of metastatic disease are large tumour diameter, ciliary body involvement, epithelioid cell type, presence of closed loops and various cytogenetic abnormalities, particularly monosomy 3 (Scholes et al 2003) .
It is common clinical practice to present survival information to the patient as the probability of survival at specified times rather than estimating time to death. Therefore, in order to conform to clinical practice, the ANN output was transformed into probability figures. The objective of this study is to create an artificial intelligence (AI) system to predict survival in patients with intraocular melanoma to support the clinicians in their diagnosis in modelling the information buried in their database. The aim was for the system to mimic the expert's knowledge and provide consistent prognosis in their absence.
Patients and methods
At the initial presentation to the ocular oncology clinic, patients underwent a full ocular and systemic examination. Tumour dimensions were measured by B-scan ultrasonography. The treatment modalities included plaque or proton beam radiotherapy, trans-scleral or trans-retinal local resection, photocoagulation or transpupillary thermotherapy and enucleation, the last being performed at the oncology centre or at the referring hospital. Histological examination was performed by staining paraffin-fixed, wax-embedded sections with haematoxylin and eosin. Patients in whom the eye was conserved were reviewed within a month of their initial treatment, then approximately every six months for about five years, and then annually. These follow-up assessments were performed at the oncology centre and at the referring hospital, in an alternating fashion, until the risk of complications was small (i.e. about 1%), when further monitoring was performed only at the referring hospital.
The database originated from patients treated in Glasgow and Liverpool, UK, between 1969 and 2001 by the same consultant clinician. Patients were included in the study if they were diagnosed as having an intraocular melanoma, clinically or histologically or both. Patients were excluded if their tumour was entirely extraocular, that is, involving only conjunctiva or eyelids.
The largest basal tumour diameter was categorized as small (i.e. <10 mm), medium (i.e. 10-15 mm) and large (i.e. >15 mm) using the same cut-offs as in the TNM clinical classification (Campbell and Sobin 1998) . Tumour location was categorized as nasal or temporal and as superior or inferior, with respect to the fovea. Anterior tumour margin was defined as anterior or posterior with respect to the ora serrata. Histologically, tumours were defined as spindle or mixed/epithelioid. All these parameters were used as inputs to the ANNs.
The clinical and pathological data were stored prospectively in a customized computerized database. Data were analysed using SPSS (version 10.0). Survival analysis was carried out using CR and Kaplan-Meier (KM) analyses.
The final observation in the database was 15 years. This time period was divided into five time intervals each containing a roughly equal number of events. These time intervals are shown in table 1 where the expression [x, y) represents a time period from x years inclusive to y years exclusive. The number of tumour specific deaths against time since initial diagnosis and the KM curves are shown in figure 1.
ANN analysis was carried out using a program written in Matlab (The Mathworks, Inc., Natick, MA) using the Neural Network Toolbox. For each time interval, a three-layer feedforward network with one hidden layer was constructed and trained by back propagation. The learning rate was varied from 0.01 to 0.1. The output layer contained one node which generated an output value ranging from 0 representing very high chance of survival to 1 representing very low chance of survival for that time interval. The ANN architecture was determined experimentally following the guidelines proposed by Demuth and Beale (2001) . The hyperbolic tangent and logarithmic sigmoid transfer functions were used for the hidden and output layers, respectively. The number of nodes in the hidden layer was varied from 1 to 10. In each case, a receiver-operating characteristic (ROC) curve was plotted to determine the optimal number of nodes. An ROC curve is a plot of sensitivity versus 1 − specificity for each possible cut-off. The area under the ROC curve (AUROC) is a measure of the model's ability to discriminate between two groups whereby an AUROC figure of 0.5 represents effectively no discrimination and 1 is maximum discrimination. The maximum number of training epochs was limited to 10 000 with the network output evaluated every 100 to reduce the possibility of overfitting.
The records in each time interval were divided into training and test sets. In order to eliminate any bias, the selection of the two groups was random and easily reproducible for the purpose of double blind analysis. This was achieved by dividing the records based on age at the time of initial diagnosis. The training set included patients whose age had an odd number at the time of treatment and tested on patients whose age had an even number.
The ANN output was transformed into a survival function using Bayes theorem as described below. If the ANN score at time interval say [T i−1 , T i ) was above a certain cut-off level ( i ), this indicated a low chance of survival beyond T i . If, on the other hand, the ANN score was < i , the record was presented to the subsequent network for time [T i , T i+1 ). then P(D) i+1 , the probability of death at the end of the time interval [i, i+1), can be calculated as
Now let
T | d i = the number of patients who died specifically from the tumour and had an ANN score value i ; t| d i = the number of patients who died specifically from the tumour and had an ANN score value < i ; T | n i = all the patients who had an ANN score i ; t| n i = all the patients who had an ANN score < i .
If S is the syndrome, represented in this case by a high ANN score, the probability of death given syndrome presence P(D|S) is calculated from Bayes as follows:
Similarly, the probability of death given no syndrome presence (i.e. low ANN score) P(D|S) is
where
For time T = 0, d i = c i = 0 and n i = 2331, the total number of records included in the study. The survival function SF can be represented by the following sequence:
Figure 2. The AI system graphical user interface using a Microsoft Visual Basic client for user interface and a Matlab engine server for the processing.
The AI system
An AI system was created by combining the mathematical power of Matlab with Microsoft Visual Basic (MS VB) in a user-friendly graphical user interface with MS VB running as a server to Matlab Active X (figure 2). The system used the combination of ANNs and Bayes as described above and plotted a survival curve. Six prognostic categories were assigned: (1) very poor, (2) poor, (3) poor/medium, (4) medium, (5) good and (other) which contained a mixture of patients who survived more than 15 years and unclassified records. Records in the test set were ranked according to their actual survival time and divided into six categories using the time intervals in table 1. The AI system was then used to predict the category they fitted in.
To demonstrate the validity of the system, a set of 34 patients who died from metastatic melanoma unseen to the training or test sets was used. The AI system was compared to the traditional CR and KM analyses. The differences of mean probability of survival at 5 years between the AI system and traditional methods were calculated using the validation set. The difference was plotted against the number of cases in the database with matching input parameters to observe the effect of increasing the number of learning and test sets.
The AI system was also assessed against a clinical expert in a double blind trial using the validation set. The differences between each prediction and the actual survival time were plotted against the survival time to visualize the performance of the clinical expert and the AI system in the short, medium and long-term survival.
Results
After excluding 263 patients with missing data, a total number of 2331 patients was included in the study. These comprised 1163 (50%) females and 1168 (50%) males. The median age was 59 years (SD = 14.7). A total of 360 patients died of metastatic melanoma. The median time to death was 3.14 years. The 1971 patients who were lost to follow-up or died of other causes had a median follow-up time of 2.48 years, exceeding 5 years in 319 patients. Table 2 shows the results of univariate analysis of risk of metastatic death according to coronal tumour location, sagittal tumour location, anterior tumour margin, largest basal tumour diameter and the cell type. The table also shows the predictive power of these parameters using CR analysis.
The number of nodes in the hidden layer for the optimum network in each time interval is shown in table 3. The table also shows the area under the ROC curves (AUROC) figure for these networks. Mean and standard deviation values for all five networks are shown in table 4 for patients who died from metastatic disease (µ TSD1 , σ TSD1 ) i and those who were alive, lost to follow-up or died of general causes (µ TSD1 , σ TSD1 ) i for i = 1, . . . , 5. The cut-off value for each time interval was calculated as
The sensitivity, specificity and accuracy of the ANN at that cut-off value are also shown in table 4. A total of six survival curves, one for each category, were constructed as shown in figure 3 . The error bars were derived from the accuracy figures in table 4. Of the 1149 patients included in the test set, 192 died from metastatic melanoma. The actual survival time for each one of these records was plotted against the category it was assigned to by the AI system as shown in figure 4. For each category, the 25th, 50th and The 5 year survival probability figure generated by the AI system was on average 41% lower than that predicted by the CR method and 37% lower than for KM. However, as can be seen from figure 5, when the number of samples increased for a particular input combination, the differences between the AI system and traditional methods decreased. For an input combination with more than 100 matching records, the mean differences were <20%. In some cases, the CR and KM methods failed to provide a result due to an insufficient number of samples.
The results of the AI system's performance versus the clinical expert's prediction are shown in figure 6 . The clinical expert was asked to predict the survival time for 34 patients, who died from intraocular melanoma. This was compared with the 25th centile figure for the category predicted by the system. The rms error of the clinical expert's prediction was 4.3 years compared to 3.7 years from the AI system.
Discussion
Two important predictor factors in survival analysis are age and sex. These two parameters however introduce a number of biases due to different patterns of withdrawals from the study for different age and sex groups. There is a sizeable amount in the literature that describes the problem and suggests methods for dealing with this bias (see, for example, Hakulinen et al 1987) . In order to examine tumour specific survival however, these two parameters have been deliberately left out in this study. Our group is currently working on including these two parameters to study the relative survival rate. The performance of the system might be further improved by excluding parameters with poor predictive power. In this study however we have only excluded parameters with large numbers of missing values.
Previous studies combining ANNs with Bayes have already been mentioned in the introduction, to generate probabilistic networks. In those studies, the database was divided into a number of prognostic groups and the theorem was used to calculate the probability of the input vector belonging to a particular group. In this study however, Bayes theorem was used for a different purpose. The theorem was used to transform the output of the ANN model into a probability figure to present the probability of survival beyond a certain time interval. The choice of the number of time intervals was therefore an important factor in the study design. A large number would result in smoother survival curves and less information loss due to grouping but at the cost of a smaller number of events in each group making it very difficult to detect an event. This was evident by the low mean figures shown in table 4. A compromise therefore had to be made between generating acceptable curves and generating ANN outputs that are above the noise level.
There were a group of patients whose risk could not be categorized by the ANNs as shown in figure 4. These might have been patients who had non-metastatic deaths, or whose death was predicted by a variable that was not considered.
The date censorship issue introduces further biasing. Patients who are alive, lost to follow-up or died of other causes are only included during the time period they were observed. Patients who die of the melanoma, on the other hand, can either be included for the whole study period or up to time of death. The former solution introduces a bias towards death which has to be rectified by deleting some records at random to match the original database as suggested by Ravdin and Clark (1992) . From our experience however, this was found to generate poor results of the networks' ability to generalize due to loss of vital information by deleting records with rare combinations. The latter solution was therefore adopted. This was found to produce better results but might also be the cause of having a relatively large number of unclassified results. Our future work will aim to address this problem.
A study in the use of computer-decision support systems in cancer showed that a significant number of clinicians preferred such systems to more traditional methods due to provision of evidence and explanations to support advice (Emery et al 2000) . Such techniques also provide consistency and are not subject to variability introduced by human factors. The role of the AI system in our study was to support the clinicians in their diagnosis in modelling the information buried in the database. It was designed to mimic the expert's knowledge and provide consistent prognosis in their absence. It was therefore initially hoped that the technique would be at least able to match the performance of the clinical expert in predicting survival. In fact, the technique exceeded expectations by outperforming the expert especially in the short and medium terms. It has been suggested in the literature that cancer survival models are only efficient for 10 years (see, for example, Moshari et al 2001) . Taking this into account, the rms error figures were re-calculated ignoring cases with >10 years survival. This presented major improvement in the AI system's performance where the rms error was 2.7 years whereas in the clinical expert's prediction there was no major improvement with an rms of 4.2 years.
Conclusion
This study showed that combining neural networks with Bayes theorem provided good representation of survival function in intraocular melanoma, predicting probability of survival at specified times rather than estimating time to death, hence conforming to usual clinical practice. The technique compared well with the traditional methods such as CR and KM analyses when the sample number was large. The technique however must be used with caution due to biasing issues as outlined in the discussion. Users of such techniques are referred to the literature describing these issues in detail, such as Ripley and Ripley (2001) .
The main strength of this study is that it can provide a valuable contribution in predicting outcomes for rare combinations of inputs where applying traditional methods is not feasible. It can also help in predicting outcomes for combinations not previously seen due to the ability of the ANNs to generalize. The main weakness of this study is that for small numbers of samples, where the differences between ANN models and statistical models were large, it is not known which model is more accurate.
This work has shown that there is a huge potential for AI techniques in modelling survival prediction in cancer. Current developments in data mining, knowledge discovery and other AI approaches require large computer resources. With the rapid development in computer science and technology, there are vast resources yet to be tapped.
